Corrigendum to “Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells” [Biomed. Pharmacother. 131 (2020) 110788] - 25/11/20

Jinar Rostami ^a, Maria Jäntti ^b, Hengjing Cui ^b, Maiju K. Rinne ^c, Jyrki P. Kukkonen ^d, Anna Falk ^e, Anna Erlandsson ^a, Timo Myöhänen ^{b, f,} ⁎

^a Molecular Geriatrics, Department of Public Health and Caring Sciences, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden 

^b Division of Pharmacology and Pharmacotherapy/Drug Research Program, University of Helsinki, Viikinkaari 5E, P.O. Box 56, 00014, University of Helsinki, Finland 

^c Division of Pharmaceutical Chemistry and Technology/Drug Research Program, Faculty of Pharmacy, P.O. Box 56, 00014, University of Helsinki, Finland 

^d Department of Pharmacology, Institute of Biomedicine, Faculty of Medicine, P.O. Box 63, 00014, University of Helsinki, Finland 

^e Department of Neuroscience, Karolinska Institutet, Stockholm 17177, Sweden 

^f Integrative Physiology and Pharmacology Unit, Institute of Biomedicine, 20014 Turun yliopisto, University of Turku, Finland 

^⁎Corresponding author at: Division of Pharmacology and Pharmacotherapy/Drug Research Program, Viikinkaari 5E, P.O. Box 56, 00014 University of Helsinki, Finland.Division of Pharmacology and Pharmacotherapy/Drug Research ProgramUniversity of HelsinkiViikinkaari 5E, P.O. Box 5600014Finland

Le texte complet de cet article est disponible en PDF.